crispr design tool Search Results


99
Transnetyx pcr genotyping
Pcr Genotyping, supplied by Transnetyx, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcr genotyping/product/Transnetyx
Average 99 stars, based on 1 article reviews
pcr genotyping - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

90
ATUM Bio grna designer tools
Grna Designer Tools, supplied by ATUM Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/grna designer tools/product/ATUM Bio
Average 90 stars, based on 1 article reviews
grna designer tools - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Broad Institute Inc crispr design tool
Crispr Design Tool, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr design tool/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
crispr design tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GenScript corporation gencrispr grna design tool
Gencrispr Grna Design Tool, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gencrispr grna design tool/product/GenScript corporation
Average 90 stars, based on 1 article reviews
gencrispr grna design tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
ATUM Bio crispr dna design tool
Crispr Dna Design Tool, supplied by ATUM Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr dna design tool/product/ATUM Bio
Average 90 stars, based on 1 article reviews
crispr dna design tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc sanger crispr webtool
Sanger Crispr Webtool, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sanger crispr webtool/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
sanger crispr webtool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GenScript corporation crispr tool
Construction and identification of the mutant virus SX1911-ΔgE/gI. ( A ) Strategy for constructing SX1911-ΔgE/gI using the <t>CRISPR/Cas9</t> and LoxP systems. <t>Two</t> <t>sgRNAs</t> were designed to guide Cas9 to delete the gE and gI genes, and GFP was used for both positive and negative screening of mutant virus production. ( B ) Identification of SX1911-ΔgE/gI via IFA and PCR targeting the gE gene. ( C ) Multistep growth curve of SX1911 and SX1911-ΔgE/gI in Vero cells. ( D ) Plaque sizes of SX1911 and SX1911-ΔgE/gI in Vero cells. Data are presented as the mean ± SD, and an asterisk indicates a significant difference between SX1911 and SX1911-ΔgE/gI. ***: p < 0.001.
Crispr Tool, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr tool/product/GenScript corporation
Average 90 stars, based on 1 article reviews
crispr tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Blue Heron Biotech crispr design tool
Construction and identification of the mutant virus SX1911-ΔgE/gI. ( A ) Strategy for constructing SX1911-ΔgE/gI using the <t>CRISPR/Cas9</t> and LoxP systems. <t>Two</t> <t>sgRNAs</t> were designed to guide Cas9 to delete the gE and gI genes, and GFP was used for both positive and negative screening of mutant virus production. ( B ) Identification of SX1911-ΔgE/gI via IFA and PCR targeting the gE gene. ( C ) Multistep growth curve of SX1911 and SX1911-ΔgE/gI in Vero cells. ( D ) Plaque sizes of SX1911 and SX1911-ΔgE/gI in Vero cells. Data are presented as the mean ± SD, and an asterisk indicates a significant difference between SX1911 and SX1911-ΔgE/gI. ***: p < 0.001.
Crispr Design Tool, supplied by Blue Heron Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr design tool/product/Blue Heron Biotech
Average 90 stars, based on 1 article reviews
crispr design tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GenScript corporation crispr sgrna design tool
Construction and identification of the mutant virus SX1911-ΔgE/gI. ( A ) Strategy for constructing SX1911-ΔgE/gI using the <t>CRISPR/Cas9</t> and LoxP systems. <t>Two</t> <t>sgRNAs</t> were designed to guide Cas9 to delete the gE and gI genes, and GFP was used for both positive and negative screening of mutant virus production. ( B ) Identification of SX1911-ΔgE/gI via IFA and PCR targeting the gE gene. ( C ) Multistep growth curve of SX1911 and SX1911-ΔgE/gI in Vero cells. ( D ) Plaque sizes of SX1911 and SX1911-ΔgE/gI in Vero cells. Data are presented as the mean ± SD, and an asterisk indicates a significant difference between SX1911 and SX1911-ΔgE/gI. ***: p < 0.001.
Crispr Sgrna Design Tool, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr sgrna design tool/product/GenScript corporation
Average 90 stars, based on 1 article reviews
crispr sgrna design tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Squarespace Inc optimized crispr design tool
Construction and identification of the mutant virus SX1911-ΔgE/gI. ( A ) Strategy for constructing SX1911-ΔgE/gI using the <t>CRISPR/Cas9</t> and LoxP systems. <t>Two</t> <t>sgRNAs</t> were designed to guide Cas9 to delete the gE and gI genes, and GFP was used for both positive and negative screening of mutant virus production. ( B ) Identification of SX1911-ΔgE/gI via IFA and PCR targeting the gE gene. ( C ) Multistep growth curve of SX1911 and SX1911-ΔgE/gI in Vero cells. ( D ) Plaque sizes of SX1911 and SX1911-ΔgE/gI in Vero cells. Data are presented as the mean ± SD, and an asterisk indicates a significant difference between SX1911 and SX1911-ΔgE/gI. ***: p < 0.001.
Optimized Crispr Design Tool, supplied by Squarespace Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optimized crispr design tool/product/Squarespace Inc
Average 90 stars, based on 1 article reviews
optimized crispr design tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Shanghai Shenggong Co crispr design tool
a Schematic representation of the strategy <t>for</t> <t>Cited1</t> knockout (KO) by the <t>CRISPR/Cas9</t> approach. The PAM sequences are in the rectangle. The cleavage site is pointed out by the scissor and arrow. Positions of the designed primers for genomic PCR are shown as arrows. The sequence of gRNA is shown in red color. b Four Cited1 KO E14T ESC cell lines with frame-shifted- or large fragment deleted- Cited1 were identified. This panel shows the genomic DNA PCR results. c Western blot analysis of protein levels of Cited1 in the parental wild-type (WT) ESCs and four Cited1 KO ESC lines after treatment with BMP4 for 6 days. d Morphology changes of parental wild-type (WT) ESCs and four Cited1 KO ESC lines before (top panel) and after (middle and bottom panels) treatment with BMP4 for 6 days. Scale bar: 200 μm (top and middle panels); 100 μm (bottom panel). e , f qRT-PCR analysis for expression levels of trophoblast ( e ) and pluripotency ( f ) markers in the four Cited1 KO ESC lines and their parental WT counterparts after treatment with BMP4 for 6 days. The comparison was made between Cited1 KO and WT ESCs at day 6 upon BMP4 treatment. The average mRNA level in untreated WT ESCs was set at 1.0. Data are shown as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001
Crispr Design Tool, supplied by Shanghai Shenggong Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crispr design tool/product/Shanghai Shenggong Co
Average 90 stars, based on 1 article reviews
crispr design tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Becton Dickinson eukaryotic pathogen crispr guide rna/ dna design tool
a Schematic representation of the strategy <t>for</t> <t>Cited1</t> knockout (KO) by the <t>CRISPR/Cas9</t> approach. The PAM sequences are in the rectangle. The cleavage site is pointed out by the scissor and arrow. Positions of the designed primers for genomic PCR are shown as arrows. The sequence of gRNA is shown in red color. b Four Cited1 KO E14T ESC cell lines with frame-shifted- or large fragment deleted- Cited1 were identified. This panel shows the genomic DNA PCR results. c Western blot analysis of protein levels of Cited1 in the parental wild-type (WT) ESCs and four Cited1 KO ESC lines after treatment with BMP4 for 6 days. d Morphology changes of parental wild-type (WT) ESCs and four Cited1 KO ESC lines before (top panel) and after (middle and bottom panels) treatment with BMP4 for 6 days. Scale bar: 200 μm (top and middle panels); 100 μm (bottom panel). e , f qRT-PCR analysis for expression levels of trophoblast ( e ) and pluripotency ( f ) markers in the four Cited1 KO ESC lines and their parental WT counterparts after treatment with BMP4 for 6 days. The comparison was made between Cited1 KO and WT ESCs at day 6 upon BMP4 treatment. The average mRNA level in untreated WT ESCs was set at 1.0. Data are shown as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001
Eukaryotic Pathogen Crispr Guide Rna/ Dna Design Tool, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eukaryotic pathogen crispr guide rna/ dna design tool/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
eukaryotic pathogen crispr guide rna/ dna design tool - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Construction and identification of the mutant virus SX1911-ΔgE/gI. ( A ) Strategy for constructing SX1911-ΔgE/gI using the CRISPR/Cas9 and LoxP systems. Two sgRNAs were designed to guide Cas9 to delete the gE and gI genes, and GFP was used for both positive and negative screening of mutant virus production. ( B ) Identification of SX1911-ΔgE/gI via IFA and PCR targeting the gE gene. ( C ) Multistep growth curve of SX1911 and SX1911-ΔgE/gI in Vero cells. ( D ) Plaque sizes of SX1911 and SX1911-ΔgE/gI in Vero cells. Data are presented as the mean ± SD, and an asterisk indicates a significant difference between SX1911 and SX1911-ΔgE/gI. ***: p < 0.001.

Journal: Viruses

Article Title: Genomic Characterization and gE/gI-Deleted Strain Construction of Novel PRV Variants Isolated in Central China

doi: 10.3390/v15061237

Figure Lengend Snippet: Construction and identification of the mutant virus SX1911-ΔgE/gI. ( A ) Strategy for constructing SX1911-ΔgE/gI using the CRISPR/Cas9 and LoxP systems. Two sgRNAs were designed to guide Cas9 to delete the gE and gI genes, and GFP was used for both positive and negative screening of mutant virus production. ( B ) Identification of SX1911-ΔgE/gI via IFA and PCR targeting the gE gene. ( C ) Multistep growth curve of SX1911 and SX1911-ΔgE/gI in Vero cells. ( D ) Plaque sizes of SX1911 and SX1911-ΔgE/gI in Vero cells. Data are presented as the mean ± SD, and an asterisk indicates a significant difference between SX1911 and SX1911-ΔgE/gI. ***: p < 0.001.

Article Snippet: sgRNAs targeting the gE and gI genes were designed using an online CRISPR tool ( https://www.genscript.com/gRNA-design-tool.html , accessed on 15 May 2021).

Techniques: Mutagenesis, Virus, CRISPR

a Schematic representation of the strategy for Cited1 knockout (KO) by the CRISPR/Cas9 approach. The PAM sequences are in the rectangle. The cleavage site is pointed out by the scissor and arrow. Positions of the designed primers for genomic PCR are shown as arrows. The sequence of gRNA is shown in red color. b Four Cited1 KO E14T ESC cell lines with frame-shifted- or large fragment deleted- Cited1 were identified. This panel shows the genomic DNA PCR results. c Western blot analysis of protein levels of Cited1 in the parental wild-type (WT) ESCs and four Cited1 KO ESC lines after treatment with BMP4 for 6 days. d Morphology changes of parental wild-type (WT) ESCs and four Cited1 KO ESC lines before (top panel) and after (middle and bottom panels) treatment with BMP4 for 6 days. Scale bar: 200 μm (top and middle panels); 100 μm (bottom panel). e , f qRT-PCR analysis for expression levels of trophoblast ( e ) and pluripotency ( f ) markers in the four Cited1 KO ESC lines and their parental WT counterparts after treatment with BMP4 for 6 days. The comparison was made between Cited1 KO and WT ESCs at day 6 upon BMP4 treatment. The average mRNA level in untreated WT ESCs was set at 1.0. Data are shown as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Cell Death & Disease

Article Title: Transcription coactivator Cited1 acts as an inducer of trophoblast-like state from mouse embryonic stem cells through the activation of BMP signaling

doi: 10.1038/s41419-018-0991-1

Figure Lengend Snippet: a Schematic representation of the strategy for Cited1 knockout (KO) by the CRISPR/Cas9 approach. The PAM sequences are in the rectangle. The cleavage site is pointed out by the scissor and arrow. Positions of the designed primers for genomic PCR are shown as arrows. The sequence of gRNA is shown in red color. b Four Cited1 KO E14T ESC cell lines with frame-shifted- or large fragment deleted- Cited1 were identified. This panel shows the genomic DNA PCR results. c Western blot analysis of protein levels of Cited1 in the parental wild-type (WT) ESCs and four Cited1 KO ESC lines after treatment with BMP4 for 6 days. d Morphology changes of parental wild-type (WT) ESCs and four Cited1 KO ESC lines before (top panel) and after (middle and bottom panels) treatment with BMP4 for 6 days. Scale bar: 200 μm (top and middle panels); 100 μm (bottom panel). e , f qRT-PCR analysis for expression levels of trophoblast ( e ) and pluripotency ( f ) markers in the four Cited1 KO ESC lines and their parental WT counterparts after treatment with BMP4 for 6 days. The comparison was made between Cited1 KO and WT ESCs at day 6 upon BMP4 treatment. The average mRNA level in untreated WT ESCs was set at 1.0. Data are shown as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: The sgRNAs targeting Cited1 and Bmpr2 locus were designed using the CRISPR Design Tool ( http://crispr.mit.edu/ ) and synthesized by the Shanghai Shenggong Company.

Techniques: Knock-Out, CRISPR, Sequencing, Western Blot, Quantitative RT-PCR, Expressing, Comparison